Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
O-1918 | 536697-79-7 | sc-202746 sc-202746A | 1 mg 5 mg | $60.00 $230.00 | ||
O-1918 is known to be a selective antagonist of the abnormal cannabidiol (abn-CBD) receptor, which may include GPR18, and can inhibit GPR18 function by preventing activation by abn-CBD-like compounds. | ||||||
JTE 907 | 282089-49-0 | sc-203616 sc-203616A | 10 mg 50 mg | $283.00 $1100.00 | ||
JTE-907 is a selective CB2 receptor inverse agonist, which may inhibit GPR18 by promoting an inactive state of the receptor due to its ability to induce conformational changes that prevent receptor activation. | ||||||
PSB-SB1202 | 1399049-60-5 | sc-476366 | 2.5 mg | $380.00 | ||
PSB-SB-1202 is a selective GPR55 antagonist that may also inhibit GPR18 by competing for overlapping ligand-binding sites or signaling pathways, thereby reducing GPR18's activity. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $72.00 $160.00 | 15 | |
Rimonabant is a CB1 receptor antagonist that can also inhibit GPR18 by occupying its binding sites, thereby preventing the receptor's normal activation by cannabinoid-like compounds. |